Abstract:The natural history of COPD is complex, and the disease is best understood as a syndrome resulting from numerous interacting factors throughout the life cycle with smoking being the strongest inciting feature. Unfortunately, diagnosis is often delayed with several longitudinal cohort studies shedding light on the long 'preclinical' period of COPD. It is now accepted that individuals presenting with different COPD phenotypes may experience varying natural history of their disease. This includes its inception, early stages and progression to established disease. Several scenarios regarding lung function course are possible, but it may conceptually be helpful to distinguish between individuals with normal maximally attained lung function in their early adulthood who thereafter experience faster than normal FEV1 decline, and those who may achieve a lower than normal maximally attained lung function. This may be the main mechanism behind COPD in the latter group, as the decline in FEV1 during their adult life may be normal or only slightly faster than normal. Regardless of the FEV1 trajectory, continuous smoking is strongly associated with disease progression, development of structural lung disease and poor prognosis. In developing countries, factors such as exposure to biomass and sequelae after tuberculosis may lead to a more airway‐centred COPD phenotype than seen in smokers. Mechanistically, COPD is characterized by a combination of structural and inflammatory changes. It is unlikely that all patients share the same individual or combined mechanisms given the heterogeneity of resultant phenotypes. Lung explants, bronchial biopsies and other tissue studies have revealed important features. At the small airway level, progression of COPD is clinically imperceptible, and the pathological course of the disease is poorly described. Asthmatic features can further add confusion. However, the small airway epithelium is likely to represent a key focus of the disease, combining impaired subepithelial crosstalk and structural/inflammatory changes. Insufficient resolution of inflammatory processes may facilitate these changes. Pathologically, epithelial metaplasia, inversion of the goblet to ciliated cell ratio, enlargement of the submucosal glands and neutrophil and CD8‐T‐cell infiltration can be detected. Evidence of type 2 inflammation is gaining interest in the light of new therapeutic agents. Alarmin biology is a promising area that may permit control of inflammation and partial reversal of structural changes in COPD. Here, we review the latest work describing the development and progression of COPD with a focus on lung function trajectories, exacerbations and survival. We also review mechanisms focusing on epithelial changes associated with COPD and lack of resolution characterizing the underlying inflammatory processes.

The persistent inflammation in COPD: is autoimmunity the core mechanism?

Anti-inflammatory effects of acupuncture in the treatment of chronic obstructive pulmonary disease

The autoimmune mechanism in infectors of chronic obstructive pulmonary disease

Autophagy in Chronic Obstructive Pulmonary Disease: Homeostatic or Pathogenic Mechanism?

Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects

Immune Dysregulation in Chronic Obstructive Pulmonary Disease

Dissociation between airway and systemic autoantibody responses in chronic obstructive pulmonary disease

Contribution of adaptive immunity to human COPD and experimental models of emphysema

Inflammation and Immune Response in COPD: Where Do We Stand?

Sputum and serum autoantibody profiles and their clinical correlation patterns in COPD patients with and without eosinophilic airway inflammation

Eosinophilic inflammation: a key player in COPD pathogenesis and progression

How Do Innate Immune Cells Contribute to Airway Remodeling in COPD Progression?

Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current Concepts and Future Strategies

Aspects on pathophysiological mechanisms in COPD

Autophagy and inflammation in chronic respiratory disease

Natural history and mechanisms of COPD

Inflammation mechanism and research progress of COPD

Role of Regulatory T Cells in Disturbed Immune Homeostasis in Patients with Chronic Obstructive Pulmonary Disease

The role of gut-lung axis in COPD: Pathogenesis, immune response, and prospective treatment

Autoinflammatory disease in the lung

The Mechanisms of Resistin-Like Molecule-β-Mediated Airway Inflammation in Chronic Obstructive Pulmonary Disease via Autophagy